Skip to content

Novel by Upper Airway Respiratory Muscle Training to Treat OSA in Chronic SCI

Novel Treatment of Sleep Apnea by Upper Airway and Respiratory Muscle Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03664765
Acronym
NOURMT-OSA
Enrollment
29
Registered
2018-09-10
Start date
2019-01-01
Completion date
2022-02-28
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA, SCI/D, Upper Airway Exercise

Keywords

OSA, SCI/D, RMT, Upper airway exercise

Brief summary

It is estimated that spinal cord injury (SCI) affects approximately 12,000 new individuals every year in the United States, with the majority are cervical and/or upper thoracic injuries. Despite this high prevalence of obstructive sleep apnea (OSA) in chronic SCI population minority of patients are treated and are adherent to standard therapy (CPAP). This proposal addresses a new therapeutic intervention for OSA in SCI. The investigators hypothesized that combined oropharyngeal and respiratory muscle exercises improve respiratory symptoms and alleviate OSA in patients with chronic SCI. The investigators will perform a pilot randomized, sham-controlled study to examine the impact of combined daily exercises (\ 30 min) for 1 and 3 months durations among Veterans with SCI. The investigators believe that this novel approach to treating OSA and will yield significant new knowledge that improves the health and quality of life of these patients.

Detailed description

In recent years, the investigators and others have discovered that spinal cord injury/disease (SCI/D) is associated with significant increase in the sleep-disordered breathing (SDB) prevalence. Nearly 80% of patients with SCI/D including Veterans suffer from SDB after six months of injury (majority of them 70-80% are obstructive apneas and hypopneas-OSA). However, most patients SCI/D do not tolerate standard SDB treatment (continuous positive airway pressure-CPAP) leading to lack of compliance. Therefore, identifying other therapies is important for this common condition that is linked to poor outcome in the general population (heart disease, stroke, hypertension and poor cognition). It has been reported in sleep apnea able-bodied patients that oropharyngeal muscle exercises for 3 months using speech pathology techniques improve the severity of SDB. Furthermore, previous studies showed respiratory muscle training (RMT) is effective for increasing respiratory muscle strength in people with cervical SCI. However, the effect of combined oropharyngeal and RMT on OSA in patients with SCI is unknown. The purpose of this application is to identify new therapeutic interventions for OSA treatment in Veterans with SCI/D. This application proposes for a pilot study to randomizing 30 Veterans with SCI/D and OSA to receive 3 months of daily (30 minutes) treatment with a validated set of oropharyngeal and RMT (intervention arm) versus sham therapy (control arm). There will be three specific aims to address the following hypotheses: Specific Aim (1): To test recruitment rate and feasibility of a pilot intervention that includes combined oropharyngeal and RMT versus sham treatment in individuals with SCI/D. Specific Aim (2): To test the acceptability and usability of combined oropharyngeal and RMT in individuals with SCI/D. Specific Aim (3): To determine the effect size estimates for clinical endpoints and their associated variability at the end of treatment to calculate an appropriate sample size for an adequately powered clinical trial.

Interventions

OTHERUA and RMT

daily oropharyngeal and respiratory muscle exercises

Daily sham exercises

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be randomized and blinded to the intervention arm (upper airway and respiratory muscle training arm) versus sham arm

Intervention model description

Randomized controlled pilot trial to assess the feasibility of using combined oropharyngeal and respiratory muscle training versus sham training on OSA in patients with chronic SCI/D

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients with chronic SCI/D (\>6 months post-injury) * American Spinal Injury Association (ASIA) classification A-D who have evidence of OSA * excluding those with no evidence of a neurologic deficit based on ASIA classification * Specifically, the study will target those with SCI/D and OSA who would like alternative treatment options or to have a lower PAP pressure, if they refused, or did not tolerate PAP treatment

Exclusion criteria

* Receiving continuous mechanical ventilation * except PAP therapy which is considered usual treatment for SDB) * Severe congestive heart failure with ejection fraction \<35% * Recent health event that may affect sleep * stroke * acute myocardial infarction * recent surgery * hospitalization * Alcohol or substance abuse (\<90 days sobriety) * Self-described as too ill to engage in study procedures * Unable to provide self-consent for participation * Central sleep apnea (CSA) defined as central apnea/hypopnea index \>50% of the AHI

Design outcomes

Primary

MeasureTime frameDescription
Feasibility-Number of Participants Who Complete the Three-month Protocol3 monthsAssess the feasibility of completing intervention arm (upper airway and respiratory muscle training arm) verses sham arm.
Recruitment3 yearsAssess the recruitment rate of the study

Countries

United States

Participant flow

Recruitment details

Participants were recruited to the primary site at John D. Dingell VA Medical Center.

Pre-assignment details

Of 188 screened, 29 participants were enrolled. Of the 29 enrolled, 24 started the study protocol.

Participants by arm

ArmCount
Intervention Exercise Arm
daily oropharyngeal and respiratory muscle exercises UA and RMT: daily oropharyngeal and respiratory muscle exercises
12
Control Arm
Daily sham exercises Sham exercise: Daily sham exercises
12
Total24

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up01
Overall StudyWithdrawal by Subject41

Baseline characteristics

CharacteristicIntervention Exercise ArmTotalControl Arm
Age, Continuous66.3 years
STANDARD_DEVIATION 10
65.4 years
STANDARD_DEVIATION 8.9
64.8 years
STANDARD_DEVIATION 7.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants9 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
8 Participants12 Participants4 Participants
Region of Enrollment
United States
12 Participants24 Participants12 Participants
Sex: Female, Male
Female
0 Participants2 Participants2 Participants
Sex: Female, Male
Male
12 Participants22 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 11
other
Total, other adverse events
0 / 120 / 11
serious
Total, serious adverse events
0 / 120 / 11

Outcome results

Primary

Feasibility-Number of Participants Who Complete the Three-month Protocol

Assess the feasibility of completing intervention arm (upper airway and respiratory muscle training arm) verses sham arm.

Time frame: 3 months

Population: This measures the number of randomized participants who stayed active in the study long enough to complete the three month protocol.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention Exercise ArmFeasibility-Number of Participants Who Complete the Three-month Protocol8 Participants
Control ArmFeasibility-Number of Participants Who Complete the Three-month Protocol10 Participants
Primary

Recruitment

Assess the recruitment rate of the study

Time frame: 3 years

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention Exercise ArmRecruitment29 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026